Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage

被引:6
作者
Chen, Chuan-Shu [1 ,2 ]
Lin, Chia-Yen [1 ,2 ,3 ]
Wang, Chun-Li [4 ]
Wang, Shian-Shiang [1 ,2 ,5 ]
Li, Jian-Ri [2 ]
Yang, Chun-Kuang [2 ]
Cheng, Chen-Li [2 ]
Chiu, Kun-Yuan [2 ,5 ]
Yang, Shun-Fa [1 ,6 ]
机构
[1] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Div Surg Crit Care, Dept Crit Care Med, Taichung, Taiwan
[4] Taichung Vet Gen Hosp, Dept Family Med, Taichung, Taiwan
[5] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan
[6] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
关键词
Urothelial carcinoma; Upper tract; Node negative; Nephroureterectomy; Survival; Lymphovascular invasion; RADICAL NEPHROURETERECTOMY; PROGNOSTIC VALUE; ADJUVANT CHEMOTHERAPY; DISSECTION;
D O I
10.1016/j.urolonc.2020.08.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To evaluate the prognostic impact of lymphovascular invasion (LVI) on node-negative upper tract urothelial carcinoma (UTUC) in patients treated with radical nephroureterectomy (RNU). Materials and methods: A retrospective study was performed in single tertiary referral center of middle Taiwan between 2001 and 2015. Seven hundred and twenty-eight patients were diagnosed of UTUC and underwent RNU with ipsilateral bladder cuff excision including 303 and 195 patients with N0 and Nx status respectively. LVI status was assessed as a prognostic factor for cancer-specific (CSS) and overall survival (OS) using univariate and multivariate Cox regression analysis. Results: LVI was observed in 82 patients (16.5%). LVI presentation associated with smoking status, advanced tumor stage, high tumor grade, positive surgical margin, and consequence lung/liver/bone metastasis. In the multivariate analysis, LVI was failed to predict CSS, OS, and disease-free survival (DFS) (hazard ratio [HR] [95% confidence interval [CI]: 1.07 [0.55-2.09], 1.05 [0.62-1.79], 1.15 [0.69-1.92], in CSS, OS, DFS, respectively). In the subgroup analysis of pT1-2 disease, the CSS, OS, and DFS were associated with LVI status (HR [95% CI]: 2.29 [0.44-11.84], 3.17 [1.16-8.67], 2.66 [1.04-6.79], in CSS, OS, DFS, respectively). In contrast, there was no difference in pT3 disease. Conclusion: In conclusion, LVI status was not associated with survival outcomes of node-negative UTUC in our study. The subgroup analysis showed different prognostic impacts of LVI status in node-negative UTUC with T1-2 and T3 stage. Further evidence to clarify the prognostic effect is needed to make LVI became a practical factor in clinical decision-making. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:132.e13 / 132.e26
页数:14
相关论文
共 27 条
  • [1] Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC).
    Birtle, Alison Jane
    Chester, John David
    Jones, Robert Jones
    Johnson, Mark
    Hill, Michaela
    Bryan, Richard T.
    Catto, James
    Donovan, Jenny
    French, Ann
    Harris, Chris
    Keeley, Francis
    Kockelbergh, Roger
    Powles, Thomas
    Todd, Rachel
    Tregellas, Lucy
    Wilson, Caroline
    Winterbottom, Andrew
    Lewis, Rebecca
    Hall, Emma
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma
    Brien, James C.
    Shariat, Shahrokh F.
    Herman, Michael P.
    Ng, Casey K.
    Scherr, Douglas S.
    Scoll, Benjamin
    Uzzo, Robert G.
    Wille, Mark
    Eggener, Scott E.
    Terrell, John D.
    Lucas, Steven M.
    Lotan, Yair
    Boorjian, Stephen A.
    Raman, Jay D.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (01) : 69 - 73
  • [3] Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival
    Colin, Pierre
    Ouzzane, Adil
    Yates, David R.
    Francois, Audenet
    Pignot, Geraldine
    Arvin-Berod, Alexis
    de Treigny, Olivier Merigot
    Laurent, Guy
    Valeri, Antoine
    Jacques, Irani
    Saint, Fabien
    Gardic, Solene
    Gres, Pascal
    Rozet, Francois
    Neuzillet, Yann
    Ruffion, Alain
    Roupret, Morgan
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) : 3613 - 3620
  • [4] The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
    Edge, Stephen B.
    Compton, Carolyn C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) : 1471 - 1474
  • [5] Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration
    Hellenthal, Nicholas J.
    Shariat, Shahrokh F.
    Margulis, Vitaly
    Karakiewicz, Pierre I.
    Roscigno, Marco
    Bolenz, Christian
    Remzi, Mesut
    Weizer, Alon
    Zigeuner, Richard
    Bensalah, Karim
    Ng, Casey K.
    Raman, Jay D.
    Kikuchi, Eiji
    Montorsi, Francesco
    Oya, Mototsugu
    Wood, Christopher G.
    Fernandez, Mario
    Evans, Christopher P.
    Koppie, Theresa M.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (03) : 900 - 906
  • [6] Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma
    Hung, Sheng-Chun
    Wang, Shian-Shiang
    Yang, Chun-Kuang
    Li, Jian-Ri
    Cheng, Chen-Li
    Ou, Yen-Chuan
    Ho, Hao-Chung
    Chiu, Kun-Yuan
    Chen, Chuan-Shu
    [J]. ANTICANCER RESEARCH, 2017, 37 (04) : 1875 - 1883
  • [7] Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy
    Hurel, Sophie
    Roupret, Morgan
    Ouzzane, Adil
    Rozet, Francois
    Xylinas, Evanguelos
    Zerbib, Marc
    Berod, Alexis Arvin
    Ruffion, Alain
    Adam, Emilie
    Cussenot, Olivier
    Houlgatte, Alain
    Phe, Veronique
    Nouhaud, Francois-Xavier
    Bensadoun, Henri
    Delage, Francky
    Guillotreau, Julien
    Guy, Laurent
    Karsenty, Gilles
    De La Taille, Alexandre
    Colin, Pierre
    [J]. BJU INTERNATIONAL, 2013, 111 (08) : 1199 - 1207
  • [8] Role of Adjuvant Chemotherapy in Advanced Stage Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: Competing Risk Analysis after Propensity Score-Matching
    Kang, Minyong
    Yoo, Heejin
    Kim, Kyunga
    Sung, Si Hyun
    Jeon, Hwang Gyun
    Park, Se Hoon
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    Jeong, Byong Chang
    [J]. JOURNAL OF CANCER, 2019, 10 (27): : 6896 - 6902
  • [9] Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma
    Kikuchi, Eiji
    Margulis, Vitaly
    Karakiewicz, Pierre I.
    Roscigno, Marco
    Mikami, Shuji
    Lotan, Yair
    Remzi, Mesut
    Bolenz, Christian
    Langner, Cord
    Weizer, Alon
    Montorsi, Francesco
    Bensalah, Karim
    Koppie, Theresa M.
    Fernandez, Mario I.
    Raman, Jay D.
    Kassouf, Wassim
    Wood, Christopher G.
    Suardi, Nazareno
    Oya, Mototsugu
    Shariat, Shahrokh F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 612 - 618
  • [10] Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract
    Kondo, Tsunenori
    Nakazawa, Hayakazu
    Ito, Fumio
    Hashimoto, Yasunobu
    Toma, Hiroshi
    Tanabe, Kazunari
    [J]. UROLOGY, 2007, 69 (02) : 265 - 269